Yahaira YoSoy

OotD: First, the fit check… then the Finer Woman check! 💙🤍✨

Switched into my Zeta Phi Beta gear and headed out to handle some thangs with my sorority sisters. Because looking good is one thing, but showing up for the work is another! 💙



🔗 https://www.instagram.com/reel/DfK0wJJTFs8/?cplk=MXBybmRpbHI3Mms4cA==

🚨 MASSACHUSETTS, WE NEED TO TALK ABOUT HEALTHCARE, DRUG PRICING, AND WHO REALLY PAYS THE PRICE.

Have you heard about the five Massachusetts hospitals suing Eli Lilly over the federal 340B drug discount program? 👀💊

This is more than a dispute between hospitals and a pharmaceutical company. It raises important questions about healthcare costs, patient privacy, access to care, and how money moves through our healthcare system.

Let’s break it down, because even if you have private or employer-sponsored health insurance, this is worth understanding.

🏥 FIRST, WHAT IS THE 340B PROGRAM?

The 340B program is a federal program that requires participating drug manufacturers to provide eligible healthcare organizations with outpatient medications at discounted prices.

Why does that matter? The program is intended to help eligible providers stretch their resources and support care for underserved and vulnerable communities.

Participating hospitals may use the savings to help support services such as community health programs, screenings, medication access, and other patient-care initiatives.

But here is something important to understand: a discounted price for a hospital does not automatically mean a lower copay for you.

If you have commercial insurance, your out-of-pocket costs are generally determined by your insurance plan's benefits and cost-sharing rules. The hospital's discounted purchase price is not automatically passed directly to you at the pharmacy counter or hospital billing desk.

⚖️ SO, WHY ARE THESE MASSACHUSETTS HOSPITALS SUING ELI LILLY?

According to recent reporting, five Massachusetts hospitals have filed a federal lawsuit challenging Eli Lilly's requirements for participating in its 340B drug discount arrangements.

The hospitals involved are:

• Massachusetts General Hospital
• Brigham and Women's Hospital
• Salem Hospital
• UMass Memorial Medical Center
• UMass Memorial Health–Harrington Hospital

At the center of the dispute is patient claims data.

The hospitals allege that Eli Lilly has tied access to certain drug discounts to the submission of claims data through a third-party platform. They argue that the requirements raise concerns about confidential patient information and that the loss of discounts could have significant financial consequences for their organizations.

Eli Lilly, meanwhile, has said the data is needed to help ensure that the program's rules are followed and that duplicate discounts do not occur.

That issue matters because federal law generally prohibits manufacturers from being required to provide both a 340B discount and a Medicaid drug rebate on the same drug.

Let's be clear: these are allegations in an ongoing legal dispute. The lawsuit itself does not establish that either side has violated the law. The courts will have to consider the arguments and evidence.

💳 WHAT DOES THIS MEAN IF YOU HAVE PRIVATE HEALTH INSURANCE?

This is where I want people to pay attention.

You might be thinking, “I have insurance through my job. Why should I care about a hospital drug discount program?”

Here are three reasons this deserves a conversation:

1️⃣ Hospital finances can affect the services available in our communities.

If hospitals lose access to discounts they rely on, that could put additional pressure on their budgets. Depending on the circumstances, that may affect how they fund certain programs or services.

However, we should not assume that every lost discount will lead to service cuts. The actual impact will depend on each hospital's finances and decisions.

2️⃣ Your insurance copay and the hospital's drug cost are two different things.

A hospital may acquire a medication at a discounted price, while the amount billed to an insurer and the patient's share of the bill are governed by separate arrangements.

So, no, this lawsuit does not automatically mean your copay is going up. And we should not claim that your premiums will increase because of this case without evidence showing that connection.

But it does give us a reason to ask broader questions about transparency, prescription drug costs, and how savings are—or are not—reflected in patient care.

3️⃣ Patient privacy matters.

Healthcare claims can contain sensitive information. We should be asking reasonable questions about what data is collected, who can access it, how it is protected, and whether the information being requested is necessary and appropriately limited.

At the same time, healthcare organizations must comply with program requirements designed to prevent duplicate discounts and other improper payments.

The challenge is figuring out how to protect patient information while maintaining accountability in a complicated healthcare system.

📢 WHY SHOULD THE PUBLIC CARE?

Because healthcare is not just about what happens when you walk into a doctor's office.

It is also about the agreements between drug manufacturers, hospitals, insurance companies, pharmacy benefit managers, and government programs.

Those agreements can influence access, affordability, and the resources available to care for patients.

And when we talk about healthcare costs, we cannot look only at the number printed on a prescription label. We need to understand the bigger picture: who negotiates the prices, who receives the savings, what patients are charged, and how the money supports—or fails to support—care.

🗣️ HERE ARE THE QUESTIONS I THINK WE SHOULD BE ASKING:

🔹 How are hospitals using the savings they receive through 340B?

🔹 What patient claims data is actually necessary to verify compliance, and what safeguards protect that information?

🔹 How can we ensure manufacturers and participating healthcare organizations follow the rules?

🔹 Are patients and the public getting enough transparency about how drug discounts affect healthcare costs and community services?

🔹 What happens to the services that rely on these savings if hospitals lose access to the discounts?

These are legitimate questions, and we deserve answers grounded in facts—not fear, assumptions, or headlines taken out of context.

📚 DO YOUR OWN RESEARCH:

📰 Boston Business Journal coverage of the lawsuit:
https://www.bizjournals.com/boston/news/2026/10/28/mass-general-umass-hospitals-sue-eli-lilly.html

🏥 Learn about the federal 340B program through the Health Resources and Services Administration:
https://www.hrsa.gov/opa/program-requirements

📣 And don't stop at sharing a post. Ask questions. Contact your elected representatives. Advocate for transparency, responsible use of healthcare resources, patient privacy, and affordable access to care.

Find your Massachusetts state legislators:
https://malegislature.gov/Search/FindMyLegislator

Find your U.S. House representative:
https://www.house.gov/representatives/find-your-representative

💬 LET'S TALK!

Did you know about the 340B program before this lawsuit? Do you think patients should have more transparency about how drug discounts and healthcare savings are used?

Share your thoughts respectfully in the comments. Let's educate ourselves, have meaningful conversations, and pay attention to the healthcare decisions that can affect our families and communities.

Because being an informed patient means understanding more than just your copay. 💙

The internet really watched Gen X grow up in real time! 😂💻 We went from AOL chat rooms, screen names, away messages, and staying up late talking to strangers online to using the same internet to educate ourselves, organize, challenge systems, and become full-blown activists.

And let’s be clear: we weren’t just online for the foolishness. 🤣 We were part of the generation that watched the internet evolve from dial-up connections and anonymous screen names to a 24/7 information highway where news spreads, communities unite, and social movements gain momentum.

We’ve lived through enough social issues, political shifts, and generational struggles to recognize patterns, question narratives, and understand why our voices matter.

Gen X didn’t just grow up with the internet. We grew alongside it. We went from logging on to see who was in the chat room to logging on to hold people, institutions, and systems accountable. 💻✊🏽

Now we’re using that same technology to educate, advocate, organize, and help the next generation understand the importance of breaking cycles instead of repeating them.

From AOL chat rooms to full-blown activism. Baby, we have HISTORY and receipts! 😂👏🏽

🇵🇷 BORICUAS, CALLING Y’ALL TO THE FRONT! 😂🇵🇷

BABYYYYY… Puffs Tissues Plus lotion got Vicks got tissues?! 😭🤣

Call your mami, abuela, tías, and the whole familia because we all know Vicks fixes EVERYTHING! 😂💀

🔗 https://link.amazon/B04snlOky

🇵🇷🤣

Two twins. One proud mama. A whole lot of memories in the making. 💙🥹

Swipe through the years, because BABYYYY… the way he went BODY TO BODY for that dunk?! 😮‍💨🔥 And the plot twist? His OWN TWIN BROTHER captured the moment! 📸😂🏀 The footage, the timing, THE BROTHERHOOD! 🫶🏽

He worked MAD HARD this summer, and watching that dedication show up on the court hits different when you’re his mama. 💪🏽💙

And for anyone who needs the reminder: BEING THE UNDERDOG IS PART OF HIS STORY, BUT IT DOES NOT DEFINE HIS STORY. ♾️💙 He has his own gifts, goals, personality, and dreams. I’m proud of the young man he’s becoming and excited to watch him keep growing into himself.

From the little boys I watched grow up to the young men they’re becoming… whew. 🥹 My heart!

His twin got the footage, the internet got the highlight, and Mama got bragging rights! 😂🏀💙

🔗 WATCH & SHARE HERE:
https://www.instagram.com/reel/De5ZvMExCYj/?xtok=MWltaXFhbjE4NjY5NA==

Please excuse the language 😂🤷🏽‍♀️ I’ll always be a hip-hop and rap mom! 🎶🔥 It’s in my DNA! 💯